Lipid phosphate phosphatase 3 in vascular pathophysiology

Area of Science:

• Molecular Biology
• Cardiovascular Research
• Enzymology

Background:

• Lipid phosphate phosphatases (LPPs) are enzymes with broad substrate specificity, including lysophosphatidic acid and sphingosine-1-phosphate.
• The LPP family in mammals comprises LPP1, LPP2, and LPP3, encoded by separate genes (PLPP1, PLPP2, PLPP3).
• While exhibiting similar in vitro activity, in vivo studies reveal distinct functions for each LPP enzyme.

Purpose of the Study:

• To review the function of LPP3 in embryonic cardiovascular development.
• To summarize experimental and clinical evidence linking LPP3 to vascular cell functions.
• To discuss the association of LPP3 with cardiovascular diseases, including atherosclerosis.

Main Methods:

• Review of existing literature on LPP3 function and genetic studies.
• Analysis of in vivo gene inactivation studies in mice.
• Examination of genome-wide association studies linking PLPP3 to disease susceptibility.

Main Results:

• Targeted inactivation of LPP3 in vivo demonstrates its critical role in vascular development.
• LPP3 plays a specific role in vascular pathophysiology and atherosclerosis development.
• Genome-wide association studies identified PLPP3 as a susceptibility locus for coronary artery disease.

Conclusions:

• LPP3 is essential for normal embryonic cardiovascular development.
• Evidence strongly implicates LPP3 in vascular pathologies and the progression of atherosclerosis.
• Further research into LPP3's role in cardiovascular disease is warranted.